1174-11-4

Xenazoic Acid has been identified in virtual screening against TRβ agonist binding pocket.

Cv 58903;Xenalmine;Xenovis.

Xenazoic acid, an antiviral agent, was introduced in the early 1960s. Its use was associated with hepatic toxicity which resulted in its withdrawal from the market in at least two countries in 1965. WHO has no information to suggest that xenazoic acid remains commercially available.